Study: Rare antibodies protect mice from deadly dose of flu virus

06/28/2010 | Reuters

Scientists at the University of Wisconsin and Theraclone Sciences in Seattle said they identified rare antibodies that proved effective in protecting 60% to 80% of mice from lethal doses of H1N1 and H5N1 flu viruses. The antibodies work by homing in on a part of the virus that does not have many mutations but is present in most influenza strains. They said the findings could pave the way for the development of a universal flu vaccine.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX